TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 15.65B USD | Liabilities, Current |
| Cash and equivalents | 3.65B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.49B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.22B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $15.65B | $3.65B | (m) | $3.49B | $3.22B | (m) |
| 2026-03-31 | (m) | $13.53B | $3.74B | (m) | $3.39B | $3.18B | (m) |
| 2025-12-31 | (m) | $13.46B | $3.56B | (m) | $3.71B | $3.18B | (m) |
| 2025-09-30 | (m) | $11.49B | $2.20B | (m) | $3.81B | $3.32B | (m) |
| 2025-06-30 | (m) | $11.86B | $2.16B | (m) | $3.56B | $3.50B | (m) |
| 2025-03-31 | (m) | $11.16B | $1.70B | (m) | $3.38B | $3.25B | (m) |
| 2024-12-31 | (m) | $12.80B | $3.30B | (m) | $3.06B | $3.01B | (m) |
| 2024-09-30 | (m) | $13.80B | $3.32B | (m) | $3.46B | $3.96B | (m) |
| 2024-06-30 | (m) | $13.04B | $2.26B | (m) | $3.77B | $3.93B | (m) |
| 2024-03-31 | (m) | $13.79B | $2.99B | (m) | $3.46B | $3.95B | (m) |
| 2023-12-31 | (m) | $12.25B | $3.23B | (m) | $3.41B | $4.02B | (m) |
| 2023-09-30 | (m) | $11.39B | $2.25B | (m) | $3.38B | $4.05B | (m) |
| 2023-06-30 | (m) | $11.84B | $2.67B | (m) | $3.54B | $4.11B | (m) |
| 2023-03-31 | (m) | $10.41B | $2.14B | (m) | $3.44B | $4.12B | (m) |
| 2022-12-31 | (m) | $11.47B | $2.80B | (m) | $3.70B | $3.83B | (m) |
| 2022-09-30 | (m) | $11.53B | $2.23B | (m) | $3.73B | $3.86B | (m) |
| 2022-06-30 | (m) | $11.00B | $2.06B | (m) | $4.47B | $4.05B | (m) |
| 2022-03-31 | (m) | $11.61B | $2.17B | (m) | $4.25B | $4.01B | (m) |
| 2021-12-31 | (m) | $11.03B | $2.17B | (m) | $4.53B | $3.82B | (m) |
| 2021-09-30 | (m) | $11.82B | $2.04B | (m) | $4.05B | $4.17B | (m) |
| 2021-06-30 | (m) | $12.69B | $2.44B | (m) | $4.49B | $4.36B | (m) |
| 2021-03-31 | (m) | $12.09B | $1.74B | (m) | $4.57B | $4.41B | (m) |
| 2020-12-31 | (m) | $13.16B | $2.18B | (m) | $4.58B | $4.40B | (m) |
| 2020-09-30 | (m) | $12.10B | $1.83B | (m) | $4.38B | $4.52B | (m) |
| 2020-06-30 | (m) | $11.75B | $2.40B | (m) | $4.54B | $4.36B | (m) |
| 2020-03-31 | (m) | $12.32B | $1.80B | (m) | $5.19B | $4.29B | (m) |
| 2019-12-31 | (m) | $13.67B | $1.98B | (m) | $5.68B | $4.42B | (m) |
| 2019-09-30 | (m) | $14.11B | $1.24B | (m) | $5.25B | $4.64B | (m) |
| 2019-06-30 | (m) | $14.45B | $2.17B | (m) | $5.26B | $4.85B | (m) |
| 2019-03-31 | (m) | $14.03B | $1.97B | (m) | $5.11B | $4.78B | (m) |
| 2018-12-31 | (m) | $14.32B | $1.78B | (m) | $5.82B | $4.73B | (m) |
| 2018-09-30 | (m) | $14.83B | $1.88B | (m) | $5.67B | $4.87B | (m) |
| 2018-06-30 | (m) | $14.21B | $1.86B | (m) | $6.06B | $4.97B | (m) |
| 2018-03-31 | (m) | $14.76B | $1.42B | (m) | $6.29B | $5.11B | (m) |
| 2017-12-31 | (m) | $17.92B | $963.00M | (m) | $7.13B | $4.92B | (m) |
| 2017-09-30 | (m) | $16.94B | $680.00M | (m) | $7.42B | $5.06B | (m) |
| 2017-06-30 | (m) | $15.46B | $599.00M | (m) | $7.32B | $5.13B | (m) |
| 2017-03-31 | (m) | $15.90B | $900.00M | (m) | $7.26B | $5.00B | (m) |
| 2016-12-31 | (m) | $18.52B | $988.00M | (m) | $7.52B | $4.95B | (m) |
| 2016-09-30 | (m) | $19.29B | $1.56B | (m) | $8.07B | $5.35B | (m) |
| 2016-06-30 | (m) | $14.41B | $6.98B | (m) | $5.37B | $3.92B | (m) |
| 2016-03-31 | (m) | $12.90B | $5.96B | (m) | $5.19B | $3.96B | (m) |
| 2015-12-31 | (m) | $13.01B | $6.95B | (m) | $5.35B | $3.97B | (m) |
| 2015-09-30 | (m) | $12.98B | $928.00M | (m) | $5.28B | $4.09B | (m) |
| 2015-06-30 | (m) | $14.47B | $1.07B | (m) | $5.57B | $4.23B | (m) |
| 2015-03-31 | (m) | $12.47B | $3.40B | (m) | $5.51B | $4.17B | (m) |
| 2014-12-31 | (m) | $12.29B | $2.23B | (m) | $5.41B | $4.37B | (m) |
| 2014-09-30 | (m) | $11.67B | $1.47B | (m) | $5.41B | $4.59B | (m) |
| 2014-06-30 | (m) | $11.85B | $949.00M | (m) | $5.39B | $4.94B | (m) |
| 2014-03-31 | (m) | $11.40B | $901.00M | (m) | $5.28B | $4.98B | (m) |
| 2013-12-31 | (m) | $11.96B | $1.04B | (m) | $5.34B | $5.05B | (m) |
| 2013-09-30 | (m) | $12.16B | $1.15B | (m) | $5.19B | $5.24B | (m) |
| 2013-06-30 | (m) | $12.84B | $1.25B | (m) | $5.30B | $5.33B | (m) |
| 2013-03-31 | (m) | $12.36B | $1.39B | (m) | $5.42B | $5.38B | (m) |
| 2012-12-31 | (m) | $12.89B | $2.88B | (m) | $5.57B | $5.50B | (m) |
| 2012-09-30 | (m) | $10.63B | $1.43B | (m) | $5.78B | $5.46B | (m) |
| 2012-06-30 | (m) | $10.01B | $1.19B | (m) | $5.43B | $5.29B | (m) |
| 2012-03-31 | (m) | $13.63B | $1.06B | (m) | $6.06B | $5.33B | (m) |
| 2011-12-31 | (m) | $13.85B | $1.10B | (m) | $6.21B | $5.01B | (m) |
| 2011-09-30 | (m) | $11.48B | $1.08B | (m) | $5.61B | $4.67B | (m) |
| 2011-06-30 | (m) | $10.05B | $1.14B | (m) | $5.47B | $4.46B | (m) |
| 2011-03-31 | (m) | $8.88B | $721.00M | (m) | $5.58B | $4.22B | (m) |
| 2010-12-31 | (m) | $9.69B | $1.25B | (m) | $5.48B | $3.87B | (m) |
| 2010-09-30 | (m) | $9.32B | $935.00M | (m) | $5.23B | $3.86B | (m) |
| 2010-06-30 | (m) | $8.18B | $4.85B | (m) | $4.99B | $3.08B | (m) |
| 2010-03-31 | (m) | $8.34B | $2.36B | (m) | $5.14B | $3.24B | (m) |
| 2009-12-31 | (m) | $7.60B | $2.00B | (m) | $5.02B | $3.33B | (m) |
| 2009-09-30 | (m) | $7.23B | $1.60B | (m) | $4.69B | $3.45B | (m) |
| 2009-06-30 | (m) | $7.24B | $1.76B | (m) | $4.38B | $3.50B | (m) |
| 2009-03-31 | (m) | $8.57B | $2.35B | (m) | $4.13B | $3.21B | (m) |
| 2008-12-31 | (m) | $8.48B | $1.85B | (m) | $4.65B | $3.40B | (m) |
| 2008-09-30 | (m) | (m) | $2.85B | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $2.48B | (m) | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | $2.51B | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $1.49B | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $1.33B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.